Login  /  Register  | 3 premium articles left before you must register.

Pfizer's RA drug wins OK in Japan

Published March 27. 2013 4:00AM

A drug brought to life by the Pfizer Inc. laboratories in Groton has earned approval from Japanese regulatory authorities.

Pfizer announced this week that the Japanese Ministry of Health, Labor and Welfare approved use of the rheumatoid arthritis pill Xeljanz for adults who don't respond well to existing therapies, such as methotrexate.

Xeljanz, which took 16 years to bring to market, was given approval by the U.S. Food and Drug Administration late last year. It previously had been known by its generic name, tofacitinib.

Pfizer said it invested more than $1 billion into the discovery, development and commercialization of Xeljanz.

- Lee Howard

News by Town

Most Recent Poll
For years, our region has been expecting big economic developments. Which of the projects below do you think will be developed first?
Fort Trumbull will be home to taxable businesses.
12%
A completed Route 11 will bring travelers straight to the heart of our region.
9%
The Coast Guard Museum will transform New London into a thriving tourist destination.
18%
The Norwich Hospital property will be an economic utopia for Preston and Norwich.
10%
Get back to me after they build Oceanquest.
52%
Number of votes: 759

No current items found